Impact of low HER2 status on CDK4/6 inhibitor and endocrine therapy in metastatic HR plus breast cancer: A retrospective multicenter study

Yildirim E. C., Atag E., Yuzugullu E., Unal O. U., Celebi A., Keser M., ...More

Congress of the European-Society-for-Medical-Oncology (ESMO), Madrid, Spain, 20 - 24 October 2023, vol.34, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 34
• Doi Number: 10.1016/j.annonc.2023.09.644
• City: Madrid
• Country: Spain
• Dokuz Eylül University Affiliated: Yes